Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 406,742 |
|
|||||
| News | - | ||||||
| Day High | 2.78 | Low High |
|||||
| Day Low | 2.70 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Arbutus Biopharma Corporation | ABUS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.01 | 0.37% | 2.73 | 16:13:59 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.73 | 2.70 | 2.78 | 2.73 | 2.72 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,760 | 406,742 | US$ 2.73 | US$ 1,110,508 | - | 1.69 - 3.29 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:20:01 | formt | 974 | US$ 2.73 | USD |
Arbutus Biopharma Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 488.22M | 179.49M | - | 18.14M | -72.85M | -0.41 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Arbutus Biopharma News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABUS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.71 | 2.81 | 2.635 | 2.71 | 683,354 | 0.02 | 0.74% |
| 1 Month | 2.61 | 3.29 | 2.30 | 2.95 | 2,182,032 | 0.12 | 4.60% |
| 3 Months | 2.37 | 3.29 | 2.265 | 2.83 | 1,443,131 | 0.36 | 15.19% |
| 6 Months | 1.73 | 3.29 | 1.70 | 2.58 | 1,057,532 | 1.00 | 57.80% |
| 1 Year | 2.55 | 3.29 | 1.69 | 2.44 | 833,614 | 0.18 | 7.06% |
| 3 Years | 3.23 | 6.50 | 1.69 | 3.50 | 1,936,098 | -0.50 | -15.48% |
| 5 Years | 2.56 | 9.00 | 0.81 | 3.67 | 2,061,200 | 0.17 | 6.64% |
Arbutus Biopharma Description
| Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology. |
